Five of the DPP-4 inhibitors (sitagliptin, vildagliptin, alogliptin, saxagliptin and linagliptin) were approved by regulatory authorities and entered the market between 2006 and 2013
Current evidence quality : Most berberine studies are relatively small, short-term (typically 816 weeks), and conducted primarily in Asian populations, which may limit generalisability
Or maybe you smell something fishy on a friend or relative and don't want to speak up
Furthermore, MELODI Presto 41 highlighted a similar mediation pathway by mining literature evidence, wherein GLP-1R agonists modulated obesity-related factors that contributed to the risk of ENOC (Supplementary Data 20)
The medication was secure inside its small box, but the overall design prioritized branding over safe handling